Alectinib
| CAS No. | 1256580-46-7 |
|---|---|
| MDL No. | MFCD19440988 |
| MF | C30H34N4O2 |
| MW | 482.60 |
| InChI Key | KDGFLJKFZUIJMX-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Alectinib is an organic heterotetracyclic compound, specifically 6,6-dimethyl-5,6-dihydro-11H-benzo[b]carbazol-11-one, with additional cyano, 4-(morpholin-4-yl)piperidin-1-yl, and ethyl substituents at positions 3, 8, and 9 respectively. It is used as the hydrochloride salt in the treatment of anaplastic lymphoma kinase-positive, metastatic non-small cell lung cancer. Alectinib functions as an EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor and an antineoplastic agent. It belongs to the classes of organic heterotetracyclic compounds, morpholines, piperidines, nitriles, and aromatic ketones, and is the conjugate base of alectinib(1+).
| CAS No. | 1256580-46-7 |
|---|---|
| Product Name | Alectinib |
Biological Targets
ALK·EML4·RET
Associated Conditions
respiratory system disease·neoplasm·sarcoma·cholangiocarcinoma·intestinal neoplasm·
* The information provided here is compiled from public sources and is for reference only.
